3 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 1 | Terminated 1 |
Follow Hypergammaglobulinemia: new trials by email Literature Review of Hypergammaglobulinemia trials Research Report on Hypergammaglobulinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma Atezolizumab (1200mg via IV infusion) - Asymptomatic Myeloma | Phase 1 | Terminated | Yale University | 2 | 2017-02-10 | 2020-03-03 |
| Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma Melphalan, Bortezomib, Dexamethasone - Plasma Cell Myeloma, Plasmacytosis | Phase 1 / Phase 2 | Terminated | University of Colorado, Denver | 3 | 2009-11-01 | 2015-03-09 |
| 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder tetradecanoylphorbol acetate - Chronic Myeloproliferative Disorders, Leukemia | Phase 1 | Terminated | University of Medicine and Dentistry of New Jersey | 1998-12-01 | 2010-01-26 |
Multiple Myeloma (2) · Smoldering Multiple Myeloma (2) · Anemia, Refractory (1) · Anemia, Refractory, with Excess of Blasts (1) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Immunoglobulin Light-chain Amyloidosis (1) · Leukemia (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Hairy Cell (1) · Leukemia, Large Granular Lymphocytic (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1)
Blood Protein Disorders (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Neoplasms (3) · Paraproteinemias (3) · Cardiovascular Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Lymphoproliferative Disorders (2) · Neoplasms by Histologic Type (2) · Precancerous Conditions (2) · Vascular Diseases (2)
Bortezomib (1) · Calcium Dobesilate (1) · Dexamethasone (1) · Melphalan (1) · Tetradecanoylphorbol Acetate (1) · Transplantation, Autologous (1) · atezolizumab (1)
University of Colorado, Denver (1) · University of Medicine and Dentistry of New Jersey (1) · Yale University (1)
United States (3)
Choon-Kee Lee, MD (1) · Noffar Bar, MD (1) · Roger Strair, MD, PhD (1)
P30CA072720 (1)